XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (416,000) $ (576,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating    
Depreciation and amortization 163,000 62,000
Equity compensation charge 9,000 122,000
Change in assets and liabilities:    
Accounts receivable 772,000 (423,000)
Inventories (175,000) 81,000
Prepaid expenses and other assets 63,000 (62,000)
Trade payables 334,000 47,000
Accrued liabilities 220,000 (18,000)
Net cash (used in) provided by operating activities 970,000 (767,000)
Cash flows from investing activities:    
Purchases of property, plant and equipment (20,000) (154,000)
Net cash (used in) provided by investing activities (20,000) (154,000)
Cash flows from financing activities:    
Receipt for preferred stock issuance 500,000
Repayment of note payable, related party (1,000,000)
Repayment of note payable (21,000) (16,000)
Net advances (repayments) on revolving line of credit (977,000) 565,000
Net cash provided by (used in) financing activities (998,000) 49,000
Net increase (decrease) in cash and cash equivalents (48,000) (872,000)
Cash and cash equivalents at beginning of period 220,000 921,000
Cash and cash equivalents at end of period 172,000 49,000
Supplemental disclosure of cash flow information and noncash investing and financing activities:    
Cash payments for interest 237,000 218,000
Accretion of dividends on preferred stock 43,000 14,000
Common stock issued in exchange for rent due to Icy Melon 182,000
Allocation of proceeds from preferred stock financing to the issuance of warrants for preferred stock 814,000
Reclassification of advances upon issuances of preferred stock $ 1,500,000